The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
The fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS), published in 2021, is the sixth version of the international standard for the classification of brain and spinal cord tumors. Building on the 2016 updated fourth edition and the work of the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy, the 2021 fifth edition introduces major changes that advance the role of molecular diagnostics in CNS tumor classification. At the same time, it remains wedded to other established approaches to tumor diagnosis such as histology and immunohistochemistry. In doing so, the fifth edition establishes some different approaches to both CNS tumor nomenclature and grading and it emphasizes the importance of integrated diagnoses and layered reports. New tumor types and subtypes are introduced, some based on novel diagnostic technologies such as DNA methylome profiling. The present review summarizes the major general changes in the 2021 fifth edition classification and the specific changes in each taxonomic category. It is hoped that this summary provides an overview to facilitate more in-depth exploration of the entire fifth edition of the WHO Classification of Tumors of the Central Nervous System.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The data considered in this study described patient populations with adult-type diffuse glioma30, and specifically displaying the radiological features of glioblastoma, scanned with mpMRI to characterize the anatomical tissue structure25.”
From Federated learning enables big data for rare cancer boundary detection (2022) · cites this paper as [30]
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Self-citationDNA methylation-based classification of central nervous system tumours
Capper, D., Jones, D. T. W., Sill, M., Hovestadt, V., Schrimpf, D., Sturm, D., Koelsche, C., Sahm, F., Chavez, L., Reuss, D. E., et al. (2018) · Nature · doi:10.1038/nature26000 · Cited by 3,033
Self-citationMolecular subgroups of medulloblastoma: the current consensus
Taylor, M. D., Northcott, P. A., Korshunov, A., Remke, M., Cho, Y.-J., Clifford, S. C., Eberhart, C. G., Parsons, D. W., Rutkowski, S., Gajjar, A., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0922-z · Cited by 1,936
Self-citationHGVS Recommendations for the Description of Sequence Variants: 2016 Update
den Dunnen, J. T., Dalgleish, R., Maglott, D. R., Hart, R. K., Greenblatt, M. S., McGowan-Jordan, J., Roux, A.-F., Smith, T., Antonarakis, S. E., Taschner, P. E. M., et al. (2016) · Human Mutation · doi:10.1002/humu.22981 · Cited by 1,653
Histological Typing of Tumours of the Central Nervous System
Kleihues, P., Burger, P. C., & Scheithauer, B. W. (1993) · Springer eBooks · doi:10.1007/978-3-642-84988-6 · Cited by 1,532
Pajtler, K. W., Witt, H., Sill, M., Jones, D. T. W., Hovestadt, V., Kratochwil, F., Wani, K., Tatevossian, R., Punchihewa, C., Johann, P., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.002 · Cited by 1,225
Self-citationIntertumoral Heterogeneity within Medulloblastoma Subgroups
Cavalli, F. M. G., Remke, M., Rampasek, L., Peacock, J., Shih, D. J. H., Luu, B., Garzia, L., Torchia, J., Nor, C., Morrissy, A. S., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.005 · Cited by 1,219
Self-citationRindi, G., Klimstra, D. S., Abedi-Ardekani, B., Asa, S. L., Bosman, F. T., Brambilla, E., Busam, K. J., de Krijger, R. R., Dietel, M., El-Naggar, A. K., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0110-y · Cited by 1,163
Self-citationBrat, D. J., Aldape, K., Colman, H., Holland, E. C., Louis, D. N., Jenkins, R. B., Kleinschmidt-DeMasters, B. K., Perry, A., Reifenberger, G., Stupp, R., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1913-0 · Cited by 896
Self-citationLouis, D. N., Perry, A., Burger, P., Ellison, D. W., Reifenberger, G., von Deimling, A., Aldape, K., Brat, D., Collins, V. P., Eberhart, C., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12171 · Cited by 580
Self-citationCapper, D., Stichel, D., Sahm, F., Jones, D. T. W., Schrimpf, D., Sill, M., Schmid, S., Hovestadt, V., Reuss, D. E., Koelsche, C., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1879-y · Cited by 567
Self-citationMedulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
Ellison, D. W., Dalton, J., Kocak, M., Nicholson, S. L., Fraga, C., Neale, G., Kenney, A. M., Brat, D. J., Perry, A., Yong, W. H., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0800-8 · Cited by 563
Self-citationLouis, D. N., Wesseling, P., Aldape, K., Brat, D. J., Capper, D., Cree, I. A., Eberhart, C., Figarella‐Branger, D., Fouladi, M., Fuller, G. N., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12832 · Cited by 525
Self-citationcIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
Brat, D. J., Aldape, K., Colman, H., Figrarella-Branger, D., Fuller, G. N., Giannini, C., Holland, E. C., Jenkins, R. B., Kleinschmidt-DeMasters, B., Komori, T., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02127-9 · Cited by 520
Self-citationSchwalbe, E. C., Lindsey, J. C., Nakjang, S., Crosier, S., Smith, A. J., Hicks, D., Rafiee, G., Hill, R. M., Iliasova, A., Stone, T., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30243-7 · Cited by 516
Müller, H. L., Merchant, T. E., Warmuth-Metz, M., Martinez-Barbera, J.-P., & Puget, S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0125-9 · Cited by 515
TERT Promoter Mutations and Risk of Recurrence in Meningioma
Sahm, F., Schrimpf, D., Olar, A., Koelsche, C., Reuss, D., Bissel, J., Kratz, A., Capper, D., Schefzyk, S., Hielscher, T., et al. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv377 · Cited by 406
Louis, D. N., Giannini, C., Capper, D., Paulus, W., Figarella-Branger, D., Lopes, M. B., Batchelor, T. T., Cairncross, J. G., van den Bent, M., Wick, W., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1826-y · Cited by 396
Self-citationAlterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
Guerreiro Stucklin, A. S., Ryall, S., Fukuoka, K., Zapotocky, M., Lassaletta, A., Li, C., Bridge, T., Kim, B., Arnoldo, A., Kowalski, P. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12187-5 · Cited by 367
Self-citationThe 2016 World Health Organization classification of tumours of the central nervous system
Villa, C., Miquel, C., Mosses, D., Bernier, M., & Di Stefano, A. L. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.04.015 · Cited by 319
Histopathologic grading of medulloblastomas: A Pediatric Oncology Group Study
Eberhart, C. G., Kepner, J. L., Goldthwaite, P. T., Kun, L. E., Duffner, P. K., Friedman, H. S., Strother, D. R., & Burger, P. C. (2002) · Cancer · doi:10.1002/cncr.10189 · Cited by 316
Sharma, T., Schwalbe, E. C., Williamson, D., Sill, M., Hovestadt, V., Mynarek, M., Rutkowski, S., Robinson, G. W., Gajjar, A., Cavalli, F., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02020-0 · Cited by 310
Self-citationEllison, D. W., Kocak, M., Figarella-Branger, D., Felice, G., Catherine, G., Pietsch, T., Frappaz, D., Massimino, M., Grill, J., Boyett, J. M., et al. (2011) · Journal of Negative Results in BioMedicine · doi:10.1186/1477-5751-10-7 · Cited by 308
Self-citationcIMPACT‐NOW update 7: advancing the molecular classification of ependymal tumors
Ellison, D. W., Aldape, K. D., Capper, D., Fouladi, M., Gilbert, M. R., Gilbertson, R. J., Hawkins, C., Merchant, T. E., Pajtler, K., Venneti, S., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12866 · Cited by 278
Self-citationISCN 2020: An International System for Human Cytogenomic Nomenclature (2020)
(2020) · KARGER eBooks · doi:10.1159/isbn.978-3-318-06867-2 · Cited by 277
Medulloblastomics revisited: biological and clinical insights from thousands of patients
Hovestadt, V., Ayrault, O., Swartling, F. J., Robinson, G. W., Pfister, S. M., & Northcott, P. A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0223-8 · Cited by 271
Self-citationClarke, M., Mackay, A., Ismer, B., Pickles, J. C., Tatevossian, R. G., Newman, S., Bale, T. A., Stoler, I., Izquierdo, E., Temelso, S., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1030 · Cited by 271
Self-citationNassiri, F., Mamatjan, Y., Suppiah, S., Badhiwala, J. H., Mansouri, S., Karimi, S., Saarela, O., Poisson, L., Gepfner-Tuma, I., Schittenhelm, J., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz061 · Cited by 267
Self-citationEllison, D. W., Hawkins, C., Jones, D. T. W., Onar-Thomas, A., Pfister, S. M., Reifenberger, G., & Louis, D. N. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01987-0 · Cited by 247
Self-citationRobinson, G. W., Rudneva, V. A., Buchhalter, I., Billups, C. A., Waszak, S. M., Smith, K. S., Bowers, D. C., Bendel, A., Fisher, P. G., Partap, S., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30204-3 · Cited by 234
Self-citationcIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)
Louis, D. N., Wesseling, P., Paulus, W., Giannini, C., Batchelor, T. T., Cairncross, J. G., Capper, D., Figarella-Branger, D., Lopes, M. B., Wick, W., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1808-0 · Cited by 229
Self-citationCDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
Sievers, P., Hielscher, T., Schrimpf, D., Stichel, D., Reuss, D. E., Berghoff, A. S., Neidert, M. C., Wirsching, H.-G., Mawrin, C., Ketter, R., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02188-w · Cited by 227
Self-citationGuidelines for human gene nomenclature
Bruford, E. A., Braschi, B., Denny, P., Jones, T. E. M., Seal, R. L., & Tweedie, S. (2020) · Nature Genetics · doi:10.1038/s41588-020-0669-3 · Cited by 218
Tesileanu, C. M. S., Dirven, L., Wijnenga, M. M. J., Koekkoek, J. A. F., Vincent, A. J. P. E., Dubbink, H. J., Atmodimedjo, P. N., Kros, J. M., van Duinen, S. G., Smits, M., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noz200 · Cited by 216
Hölsken, A., Sill, M., Merkle, J., Schweizer, L., Buchfelder, M., Flitsch, J., Fahlbusch, R., Metzler, M., Kool, M., Pfister, S. M., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0287-6 · Cited by 195
Self-citationMethylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre
Jaunmuktane, Z., Capper, D., Jones, D. T. W., Schrimpf, D., Sill, M., Dutt, M., Suraweera, N., Pfister, S. M., von Deimling, A., & Brandner, S. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0668-8 · Cited by 182
Self-citationHerraiz, C., Calvo, F., Pandya, P., Cantelli, G., Rodriguez-Hernandez, I., Orgaz, J. L., Kang, N., Chu, T., Sahai, E., & Sanz-Moreno, V. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv289 · Cited by 180
Spindle Cell Oncocytomas and Granular Cell Tumors of the Pituitary Are Variants of Pituicytoma
Mete, O., Lopes, M. B., & Asa, S. L. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31829723e7 · Cited by 175
McGowan-Jordan, J., Hastings, R., & Moore, S. (2021) · Cytogenetic and Genome Research · doi:10.1159/000516655 · Cited by 169
Louis, D. N., Aldape, K. D., Brat, D. J., Capper, D., Ellison, D. W., Hawkins, C. E., Paulus, W., Perry, A., Reifenberger, G., Figarella-Branger, D. F., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1646-x · Cited by 155
Self-citationMcManamy, C. S., Pears, J., Weston, C. L., Hanzely, Z., Ironside, J. W., Taylor, R. E., Grundy, R. G., Clifford, S. C., Ellison, D. W., & on behalf of the Clinical Brain Tumour Group, C. C. A. L. G. (. T. U. C. C. S. G. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00058.x · Cited by 146
Self-citationSievers, P., Sill, M., Schrimpf, D., Stichel, D., Reuß, D., Sturm, D., Hench, J., Frank, S., Krsková, L., Vícha, A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa251 · Cited by 139
Self-citationClinical course and progression-free survival of adult intracranial and spinal ependymoma patients
Vera‐Bolanos, E., Aldape, K., Yuan, Y., Wu, J., Wani, K., Necesito-Reyes, M. J., Colman, H., Dhall, G., Lieberman, F. S., Métellus, P., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou162 · Cited by 132
Self-citationLi, B. K., Vasiljevic, A., Dufour, C., Yao, F., Ho, B., Lu, M., Hwang, E. I., Gururangan, S., Hansford, J. R., Fouladi, M., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02111-y · Cited by 122
Self-citationBrain tumour diagnostics using a DNA methylation‐based classifier as a diagnostic support tool
Priesterbach-Ackley, L. P., Boldt, H. B., Petersen, J. K., Bervoets, N., Scheie, D., Ulhøi, B. P., Gardberg, M., Brännström, T., TORP, S. H., Aronica, E., et al. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12610 · Cited by 121
Self-citationMorphophenotypic Variation Predicts Clinical Behavior in Childhood Non-Desmoplastic Medulloblastomas
McManamy, C. S., Lamont, J. M., Taylor, R. E., Cole, M. F., Pearson, A. D. J., Clifford, S. C., & Ellison, D. W. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.6.627 · Cited by 120
Self-citationMynarek, M., von Hoff, K., Pietsch, T., Ottensmeier, H., Warmuth-Metz, M., Bison, B., Pfister, S., Korshunov, A., Sharma, T., Jaeger, N., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.03057 · Cited by 106
Self-citationThe 2000 World Health Organization classification of tumours of the nervous system
Gonzales, M. F. (2001) · Journal of Clinical Neuroscience · doi:10.1054/jocn.2000.0829 · Cited by 97
Pfaff, E., Aichmüller, C., Sill, M., Stichel, D., Snuderl, M., Karajannis, M. A., Schuhmann, M. U., Schittenhelm, J., Hasselblatt, M., Thomas, C., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-019-02101-0 · Cited by 92
Self-citationLouis, D. N., Aldape, K. D., Brat, D. J., Capper, D., Ellison, D. W., Hawkins, C. E., Paulus, W., Perry, A., Reifenberger, G., Figarella-Branger, D. F., et al. (2016) · Brain Pathology · doi:10.1111/bpa.12457 · Cited by 89
Self-citationMedulloblastoma genomics in the modern molecular era
Kumar, R., Liu, A. P. Y., & Northcott, P. A. (2019) · Brain Pathology · doi:10.1111/bpa.12804 · Cited by 85
Vaubel, R. A., Chen, S. G., Raleigh, D. R., Link, M. J., Chicoine, M. R., Barani, I. J., Jenkins, S. M., Abell-Aleff, P. C., Rodríguez, F. J., Burger, P. C., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv006 · Cited by 83
Self-citationcIMPACT‐NOW: a practical summary of diagnostic points from Round 1 updates
Louis, D. N., Ellison, D. W., Brat, D. J., Aldape, K., Capper, D., Hawkins, C. E., Paulus, W., Perry, A., Reifenberger, G., Figarella-Branger, D. F., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12732 · Cited by 82
Self-citationEWSR1‐PATZ1 gene fusion may define a new glioneuronal tumor entity
Siegfried, A., Rousseau, A., Maurage, C., Péricart, S., Nicaise, Y., Escudié, F., Grand, D., Delrieu, A., Gomez‐Brouchet, A., Guellec, S. L., et al. (2018) · Brain Pathology · doi:10.1111/bpa.12619 · Cited by 78
Self-citationThomas, C., Wefers, A. K., Bens, S., Nemes, K., Agaimy, A., Oyen, F., Vogelgesang, S., Rodríguez, F. J., Brett, F. M., McLendon, R. E., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02094-w · Cited by 77
Self-citationLee, J. C., Mazor, T., Lao, R., Wan, E., Diallo, A. B., Hill, N. S., Thangaraj, N., Wendelsdorf, K., Samuel, D., Kline, C. N., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01990-5 · Cited by 71
Self-citationOno, T., Shirahata, M., Louis, D. N., & von Deimling, A. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1636430 · Cited by 65
Self-citationGauchotte, G., Peyre, M., Pouget, C., Cazals-Hatem, D. L., Polivka, M., Rech, F., Varlet, P., Loiseau, H., Lacomme, S., Mokhtari, K., et al. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa038 · Cited by 65
Stichel, D., Schrimpf, D., Casalini, B., Meyer, J., Wefers, A. K., Sievers, P., Korshunov, A., Koelsche, C., Reuß, D., Reinhardt, A., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02039-3 · Cited by 56
Self-citationHistological variants of medulloblastoma are the most powerful clinical prognostic indicators
Massimino, M., Antonelli, M., Gandola, L., Miceli, R., Pollo, B., Biassoni, V., Schiavello, E., Buttarelli, F. R., Spreafico, F., Collini, P., et al. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24225 · Cited by 52
Santosh, V., Palavalasa, S., Gupta, T., Muzumdar, D., Chacko, G., Suri, V. S., Epari, S., Balasubramaniam, A., Radotra, B., Chatterjee, S., et al. (2019) · Neurology India · doi:10.4103/0028-3886.253572 · Cited by 52
Hussein, S. E., & Vincentelli, C. (2017) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2017.05.004 · Cited by 40
Aldape, K., Nejad, R., Louis, D. N., & Zadeh, G. M. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now181 · Cited by 33
Self-citationLouis, D. N., Wesseling, P., Brandner, S., Brat, D. J., Ellison, D. W., Giangaspero, F., Hattab, E. M., Hawkins, C. E., Judge, M. J., Kleinschmidt-DeMasters, B. K., et al. (2019) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2018-0565-oa · Cited by 27
Self-citationBurel‐Vandenbos, F., Pierron, G., Thomas, C., Reynaud, S., Gregoire, V., de Bénazé, G. D., Croze, S., Chivoret, N., Honavar, M., Figarella-Branger, D. F., et al. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12626 · Cited by 26
Self-citationGrading of diffuse astrocytic gliomas: Broders, Kernohan, Zülch, the WHO… and Shakespeare
Louis, D. N., & von Deimling, A. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1765-z · Cited by 24
Self-citationAndreiuolo, F. D. M., Mazeraud, A., Chrétien, F. C., & Pietsch, T. (2016) · Brain Pathology · doi:10.1111/bpa.12383 · Cited by 22
Genomics Paves the Way for Better Infant Medulloblastoma Therapy
Robinson, G. W., & Gajjar, A. J. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00593 · Cited by 22
Practical procedures for the integrated diagnosis of astrocytic and oligodendroglial tumors
Sonoda, Y., Yokoo, H., Tanaka, S., Kinoshita, M., Nakada, M., & Nishihara, H. (2019) · Brain Tumor Pathology · doi:10.1007/s10014-019-00337-y · Cited by 19
Research works printed but not linked: 2
- WHO Classification of Tumours Editorial Board., 2021, World Health Organization Classification of Tumours of the Central Nervous System
- Zulch, 1979, Histological Typing of Tumours of the Central Nervous System
Cited by
Ostrom, Q. T., Cioffi, G., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab200 · Cited by 2,529
Ostrom, Q. T., Price, M., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac202 · Cited by 1,565
Ostrom, Q. T., Price, M., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad149 · Cited by 1,294
Glioblastoma and Other Primary Brain Malignancies in Adults: A Review
Schaff, L. R., & Mellinghoff, I. K. (2023) · JAMA · doi:10.1001/jama.2023.0023 · Cited by 1,271
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Mellinghoff, I. K., van den Bent, M. J., Blumenthal, D. T., Touat, M., Peters, K. B., Clarke, J., Mendez, J., Yust-Katz, S., Welsh, L., Mason, W. P., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2304194 · Cited by 814
Self-citation
Metadata
- Authors
- Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., Hawkins, C., Ng, H. K., Pfister, S. M., Reifenberger, G., Soffietti, R., von Deimling, A., & Ellison, D. W.
- Affiliations
- Harvard University (US)
- University of California, San Francisco (US)
- Princess Máxima Center (NL)
- Northwestern University (US)
- Centre international de recherche sur le cancer (FR)
- Centre National de la Recherche Scientifique (FR)
- University of Toronto (CA)
- Chinese University of Hong Kong (HK)
- German Cancer Research Center (DE)
- Düsseldorf University Hospital (DE)
- University of Turin (IT)
- Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Louis, David N
- ORCID
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-06-29
- Volume
- 23
- Issue
- 8
- Pages
- 1231-1251
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- PMC
- PMC8328013
- OpenAlex
- W3174246647
- Cited by
- 12,273
- References
- 69
- Citations by year
- 2026: 2346 · 2025: 2620 · 2024: 2786 · 2023: 2459 · 2022: 1743 · 2021: 262
- FWCI
- 264.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Neuro-Oncology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- World Health Organization
- Brain Tumour Charity (GN-000382)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Clinical Neurology › Meningioma and schwannoma management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- brain tumors, spinal cord tumors, tumor classification, molecular diagnosis, tumor nomenclature, tumor grading, histology, immunohistochemistry, integrated diagnosis
- MeSH terms
- Brain, Central Nervous System, Humans, World Health Organization, Central Nervous System Neoplasms, Pathology, Molecular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.